Literature DB >> 3908105

The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction.

W S Hillis, R S Hornung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3908105     DOI： 10.1093/oxfordjournals.eurheartj.a061787

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  8 in total

Review 1.  Drug utilisation review and pharmacoeconomics: interaction after parallel development?

Authors:  S Garattini; G Tognoni
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

2.  Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.

Authors:  J P Monassier; M Hanssen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Thrombolytic treatment and new calcium antagonists.

Authors:  J Feely; T Pringle; D Maclean
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05

4.  Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States.

Authors:  J L Anderson
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  A randomised placebo-controlled pilot dose-response study with anisoylated plasminogen streptokinase activator complex in acute coronary artery occlusions.

Authors:  A Leizorovicz; G Durrieu; J P Boissel
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.

Authors:  R Seabra-Gomes; J Aniceto Silva; A Aleixo; T Real; I Freire; I Torres; R Freitas; F Crespo
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.

Authors:  M Samama; J Conard; E Verdy; P van Dreden; G Nguyen; A Combrisson; J Acar
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 8.  Anisoylated plasminogen streptokinase activator complex (APSAC). A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarction.

Authors:  J P Monk; R C Heel
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.